Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.68367467 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.33314732 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.33314732 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.87953745 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77754074 |
6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.47070068 |
7 | protein localization to endosome (GO:0036010) | 4.12892591 |
8 | response to peptidoglycan (GO:0032494) | 4.04629565 |
9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88898355 |
10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66293848 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.61331549 |
12 | immunoglobulin mediated immune response (GO:0016064) | 3.59209075 |
13 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.57921584 |
14 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.47473021 |
15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43800154 |
16 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.41453711 |
17 | regulation of B cell differentiation (GO:0045577) | 3.37588532 |
18 | pinocytosis (GO:0006907) | 3.34964364 |
19 | regulation of response to interferon-gamma (GO:0060330) | 3.33270413 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 3.31533588 |
21 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.28148331 |
22 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.27907010 |
23 | natural killer cell mediated immunity (GO:0002228) | 3.27907010 |
24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.26136582 |
25 | B cell mediated immunity (GO:0019724) | 3.22475269 |
26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.19555224 |
27 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.13060551 |
28 | macrophage activation involved in immune response (GO:0002281) | 3.10440447 |
29 | natural killer cell differentiation (GO:0001779) | 3.08286062 |
30 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.04245659 |
31 | modulation by symbiont of host cellular process (GO:0044068) | 3.03290360 |
32 | DNA deamination (GO:0045006) | 3.02767200 |
33 | leukocyte aggregation (GO:0070486) | 3.02673380 |
34 | NIK/NF-kappaB signaling (GO:0038061) | 3.00547207 |
35 | response to muramyl dipeptide (GO:0032495) | 2.97352600 |
36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96987367 |
37 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.91801074 |
38 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.90963040 |
39 | barbed-end actin filament capping (GO:0051016) | 2.89938602 |
40 | type I interferon signaling pathway (GO:0060337) | 2.88896814 |
41 | cellular response to type I interferon (GO:0071357) | 2.88896814 |
42 | regulation of early endosome to late endosome transport (GO:2000641) | 2.88209787 |
43 | response to type I interferon (GO:0034340) | 2.87632092 |
44 | positive regulation of interferon-beta production (GO:0032728) | 2.87273862 |
45 | T cell apoptotic process (GO:0070231) | 2.87114671 |
46 | positive regulation of B cell differentiation (GO:0045579) | 2.85453853 |
47 | positive regulation of macrophage differentiation (GO:0045651) | 2.83360442 |
48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.83206756 |
49 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.82764704 |
50 | defense response to protozoan (GO:0042832) | 2.81985509 |
51 | mannose metabolic process (GO:0006013) | 2.81277625 |
52 | response to interleukin-15 (GO:0070672) | 2.80820587 |
53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80557289 |
54 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.80505709 |
55 | negative regulation of cell killing (GO:0031342) | 2.79985529 |
56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79985529 |
57 | positive regulation of interferon-alpha production (GO:0032727) | 2.79005104 |
58 | glycosphingolipid catabolic process (GO:0046479) | 2.76328286 |
59 | B cell receptor signaling pathway (GO:0050853) | 2.75576043 |
60 | negative regulation of viral release from host cell (GO:1902187) | 2.74391290 |
61 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.73900574 |
62 | T cell costimulation (GO:0031295) | 2.73096624 |
63 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.72978550 |
64 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.72500129 |
65 | response to laminar fluid shear stress (GO:0034616) | 2.72155381 |
66 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.71807612 |
67 | lymphocyte costimulation (GO:0031294) | 2.71662552 |
68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.71536761 |
69 | regulation of leukocyte degranulation (GO:0043300) | 2.71378684 |
70 | negative thymic T cell selection (GO:0045060) | 2.70189559 |
71 | apoptotic process involved in morphogenesis (GO:0060561) | 2.69021737 |
72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.68934930 |
73 | positive thymic T cell selection (GO:0045059) | 2.68247019 |
74 | amyloid precursor protein catabolic process (GO:0042987) | 2.67681639 |
75 | positive regulation of lamellipodium assembly (GO:0010592) | 2.66662231 |
76 | response to protozoan (GO:0001562) | 2.64290524 |
77 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.64134379 |
78 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.63178286 |
79 | formation of translation preinitiation complex (GO:0001731) | 2.62593390 |
80 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62120610 |
81 | myeloid dendritic cell differentiation (GO:0043011) | 2.62042501 |
82 | regulation of superoxide anion generation (GO:0032928) | 2.62008964 |
83 | detection of other organism (GO:0098543) | 2.61490924 |
84 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.61328301 |
85 | negative T cell selection (GO:0043383) | 2.60952711 |
86 | regulation of interferon-alpha production (GO:0032647) | 2.59553880 |
87 | natural killer cell activation (GO:0030101) | 2.57568232 |
88 | stress fiber assembly (GO:0043149) | 2.57516848 |
89 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.55887315 |
90 | amino sugar catabolic process (GO:0046348) | 2.55426701 |
91 | thymic T cell selection (GO:0045061) | 2.55413236 |
92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54736296 |
93 | lymphocyte apoptotic process (GO:0070227) | 2.54386978 |
94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53637295 |
95 | regulation of podosome assembly (GO:0071801) | 2.53393757 |
96 | detection of bacterium (GO:0016045) | 2.53061106 |
97 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.52709930 |
98 | Peyers patch development (GO:0048541) | 2.52709930 |
99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.52350430 |
100 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.52257572 |
101 | modulation by virus of host process (GO:0019054) | 2.51175467 |
102 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51122329 |
103 | oligosaccharide catabolic process (GO:0009313) | 2.50041074 |
104 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49940054 |
105 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.49230379 |
106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.49230379 |
107 | glycolipid catabolic process (GO:0019377) | 2.48975586 |
108 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.48298079 |
109 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.48298079 |
110 | positive regulation of mast cell activation (GO:0033005) | 2.47066711 |
111 | cellular response to zinc ion (GO:0071294) | 2.46186814 |
112 | cellular response to interleukin-15 (GO:0071350) | 2.46167531 |
113 | positive regulation of humoral immune response (GO:0002922) | 2.45811696 |
114 | ribosome assembly (GO:0042255) | 2.45227830 |
115 | regulation of necroptotic process (GO:0060544) | 2.44954560 |
116 | activation of MAPKKK activity (GO:0000185) | 2.44607369 |
117 | regulation of protein heterodimerization activity (GO:0043497) | 2.44476857 |
118 | positive regulation of isotype switching (GO:0045830) | 2.44199560 |
119 | pentose-phosphate shunt (GO:0006098) | 2.43505071 |
120 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43327202 |
121 | cellular response to interferon-beta (GO:0035458) | 2.42715153 |
122 | actin nucleation (GO:0045010) | 2.42430240 |
123 | embryonic process involved in female pregnancy (GO:0060136) | 2.42200771 |
124 | skin morphogenesis (GO:0043589) | 2.41828594 |
125 | regulation of necrotic cell death (GO:0010939) | 2.41553825 |
126 | cellular response to arsenic-containing substance (GO:0071243) | 2.40854645 |
127 | myeloid dendritic cell activation (GO:0001773) | 2.40734758 |
128 | regulation of mast cell degranulation (GO:0043304) | 2.39811312 |
129 | positive regulation of lamellipodium organization (GO:1902745) | 2.37481759 |
130 | regulation of chronic inflammatory response (GO:0002676) | 2.37342373 |
131 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.37301769 |
132 | leukocyte cell-cell adhesion (GO:0007159) | 2.36754940 |
133 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36374796 |
134 | modulation by symbiont of host defense response (GO:0052031) | 2.36374796 |
135 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36374796 |
136 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36374796 |
137 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36374796 |
138 | modulation by symbiont of host immune response (GO:0052553) | 2.36374796 |
139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.35912567 |
140 | response to interferon-beta (GO:0035456) | 2.35857225 |
141 | neutrophil activation involved in immune response (GO:0002283) | 2.34803967 |
142 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33248650 |
143 | platelet aggregation (GO:0070527) | 2.29179508 |
144 | proline biosynthetic process (GO:0006561) | 2.28963556 |
145 | COPI coating of Golgi vesicle (GO:0048205) | 2.28933390 |
146 | Golgi transport vesicle coating (GO:0048200) | 2.28933390 |
147 | lymphocyte mediated immunity (GO:0002449) | 2.28530339 |
148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.28197401 |
149 | response to host (GO:0075136) | 2.28197401 |
150 | response to host defenses (GO:0052200) | 2.28197401 |
151 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.27977385 |
152 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.27920687 |
153 | response to thyroid hormone (GO:0097066) | 2.27662127 |
154 | regulation of vitamin metabolic process (GO:0030656) | 2.26917605 |
155 | detection of external biotic stimulus (GO:0098581) | 2.26900506 |
156 | T cell migration (GO:0072678) | 2.26785893 |
157 | low-density lipoprotein particle clearance (GO:0034383) | 2.24583099 |
158 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.24403190 |
159 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.24079522 |
160 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.23515254 |
161 | germinal center formation (GO:0002467) | 2.23391542 |
162 | negative regulation of necroptotic process (GO:0060546) | 2.23261533 |
163 | detection of molecule of bacterial origin (GO:0032490) | 2.23245824 |
164 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.23194128 |
165 | activation of Rac GTPase activity (GO:0032863) | 2.22692333 |
166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21335154 |
167 | response to host immune response (GO:0052572) | 2.21335154 |
168 | maternal placenta development (GO:0001893) | 2.18906311 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38091930 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35396231 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.26774857 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.94313461 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57844586 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42013626 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38603608 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 2.34910567 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.33543408 |
10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22981775 |
11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21556628 |
12 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16604157 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12060165 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.99553799 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98957806 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97488682 |
17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95768641 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92199116 |
19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.90889849 |
20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83838904 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82907848 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80411233 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79275142 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 1.75655462 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75368699 |
26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74952467 |
27 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74834138 |
28 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74095411 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71194814 |
30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64473846 |
31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63706268 |
32 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63486837 |
33 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60104358 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 1.58015595 |
35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57506305 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56666264 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56003278 |
38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55567073 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.52122805 |
40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.49511050 |
41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49296586 |
42 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48614535 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48225326 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48093220 |
45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46334633 |
46 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45992880 |
47 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45169039 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43729488 |
49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41748847 |
50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41656690 |
51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41603307 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40174239 |
53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39667047 |
54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38972911 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38622607 |
56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38398036 |
57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36978055 |
58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36884330 |
59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35710025 |
60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33455630 |
61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32574243 |
62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32242496 |
63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32177254 |
64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.31679657 |
65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30979890 |
66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29853317 |
67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28962108 |
68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28330368 |
69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28115620 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.27866871 |
71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27735133 |
72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27263698 |
73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27137493 |
74 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26861064 |
75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26729860 |
76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25632047 |
77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25049171 |
78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24979602 |
79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24746016 |
80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24507441 |
81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21909950 |
82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21807476 |
83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21689277 |
84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21106117 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20965271 |
86 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20964069 |
87 | P68_20966046_ChIP-Seq_HELA_Human | 1.20912298 |
88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19826367 |
89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19750740 |
90 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18154448 |
91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18003548 |
92 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16863151 |
93 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15458817 |
94 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13849144 |
95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12849188 |
96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12406360 |
97 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12398393 |
98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11876052 |
99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11827720 |
100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11025108 |
101 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11008142 |
102 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10005017 |
103 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09809091 |
104 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08573089 |
105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08149063 |
106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07910018 |
107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07546226 |
108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07466609 |
109 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07025729 |
110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06656588 |
111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06474789 |
112 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05929336 |
113 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04786643 |
114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04760846 |
115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04093230 |
116 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03749689 |
117 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02963153 |
118 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02857734 |
119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01880712 |
120 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01425558 |
121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01254691 |
122 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01180568 |
123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00176214 |
124 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99408501 |
125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99307092 |
126 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99195722 |
127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98504670 |
128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98428569 |
129 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97966546 |
130 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97960987 |
131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97818794 |
132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97797037 |
133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97792509 |
134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97669359 |
135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97629289 |
136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97220322 |
137 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96687486 |
138 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.96674886 |
139 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96652874 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.27357955 |
2 | MP0000685_abnormal_immune_system | 3.02511209 |
3 | MP0005671_abnormal_response_to | 2.74588327 |
4 | MP0009785_altered_susceptibility_to | 2.60119288 |
5 | MP0009840_abnormal_foam_cell | 2.50419859 |
6 | MP0005058_abnormal_lysosome_morphology | 2.47385221 |
7 | MP0003436_decreased_susceptibility_to | 2.44700458 |
8 | MP0009333_abnormal_splenocyte_physiolog | 2.39757692 |
9 | MP0005000_abnormal_immune_tolerance | 2.32711587 |
10 | MP0001800_abnormal_humoral_immune | 2.31865530 |
11 | MP0003763_abnormal_thymus_physiology | 2.27797247 |
12 | MP0003303_peritoneal_inflammation | 2.27325692 |
13 | MP0002452_abnormal_antigen_presenting | 2.23670464 |
14 | MP0006082_CNS_inflammation | 2.23290920 |
15 | MP0002723_abnormal_immune_serum | 2.22377011 |
16 | MP0005387_immune_system_phenotype | 2.21223121 |
17 | MP0001790_abnormal_immune_system | 2.21223121 |
18 | MP0005025_abnormal_response_to | 2.16743942 |
19 | MP0002396_abnormal_hematopoietic_system | 2.13192729 |
20 | MP0010234_abnormal_vibrissa_follicle | 2.11867890 |
21 | MP0001819_abnormal_immune_cell | 2.11739101 |
22 | MP0002420_abnormal_adaptive_immunity | 2.11578173 |
23 | MP0004510_myositis | 2.06024342 |
24 | * MP0002398_abnormal_bone_marrow | 2.02415351 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.00311404 |
26 | MP0002419_abnormal_innate_immunity | 1.97780207 |
27 | MP0002405_respiratory_system_inflammati | 1.94204033 |
28 | MP0005310_abnormal_salivary_gland | 1.84251456 |
29 | MP0000716_abnormal_immune_system | 1.83980518 |
30 | MP0004947_skin_inflammation | 1.82308530 |
31 | MP0002166_altered_tumor_susceptibility | 1.80333607 |
32 | MP0000689_abnormal_spleen_morphology | 1.79571555 |
33 | MP0001853_heart_inflammation | 1.79199890 |
34 | MP0002722_abnormal_immune_system | 1.76033202 |
35 | MP0003693_abnormal_embryo_hatching | 1.71854700 |
36 | MP0001849_ear_inflammation | 1.70236022 |
37 | MP0001845_abnormal_inflammatory_respons | 1.62960283 |
38 | MP0010155_abnormal_intestine_physiology | 1.62219689 |
39 | MP0000858_altered_metastatic_potential | 1.61262783 |
40 | * MP0005464_abnormal_platelet_physiology | 1.59362776 |
41 | * MP0002429_abnormal_blood_cell | 1.58087818 |
42 | MP0003705_abnormal_hypodermis_morpholog | 1.54749297 |
43 | MP0003646_muscle_fatigue | 1.51041633 |
44 | MP0005397_hematopoietic_system_phenotyp | 1.49144712 |
45 | MP0001545_abnormal_hematopoietic_system | 1.49144712 |
46 | MP0004185_abnormal_adipocyte_glucose | 1.47764250 |
47 | MP0010352_gastrointestinal_tract_polyps | 1.43139863 |
48 | MP0002796_impaired_skin_barrier | 1.42413721 |
49 | MP0003075_altered_response_to | 1.40049472 |
50 | MP0003172_abnormal_lysosome_physiology | 1.37966186 |
51 | MP0002006_tumorigenesis | 1.36293582 |
52 | MP0008469_abnormal_protein_level | 1.34940196 |
53 | MP0002877_abnormal_melanocyte_morpholog | 1.33260924 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.32505623 |
55 | MP0000703_abnormal_thymus_morphology | 1.32425783 |
56 | MP0002998_abnormal_bone_remodeling | 1.30844028 |
57 | MP0001873_stomach_inflammation | 1.30742097 |
58 | MP0000343_altered_response_to | 1.30680856 |
59 | MP0000490_abnormal_crypts_of | 1.28822556 |
60 | MP0003077_abnormal_cell_cycle | 1.24834532 |
61 | MP0003566_abnormal_cell_adhesion | 1.24651361 |
62 | MP0003300_gastrointestinal_ulcer | 1.24394478 |
63 | MP0004957_abnormal_blastocyst_morpholog | 1.24381929 |
64 | MP0002254_reproductive_system_inflammat | 1.22604427 |
65 | MP0004233_abnormal_muscle_weight | 1.21040725 |
66 | MP0003448_altered_tumor_morphology | 1.20862848 |
67 | MP0010307_abnormal_tumor_latency | 1.18717062 |
68 | MP0004808_abnormal_hematopoietic_stem | 1.17473293 |
69 | MP0003111_abnormal_nucleus_morphology | 1.15946782 |
70 | MP0002019_abnormal_tumor_incidence | 1.15857406 |
71 | MP0002933_joint_inflammation | 1.15799118 |
72 | MP0005501_abnormal_skin_physiology | 1.13666622 |
73 | MP0005023_abnormal_wound_healing | 1.12666864 |
74 | MP0001533_abnormal_skeleton_physiology | 1.12279796 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 1.10788834 |
76 | MP0004858_abnormal_nervous_system | 1.10006581 |
77 | MP0003828_pulmonary_edema | 1.09890210 |
78 | MP0003866_abnormal_defecation | 1.09151308 |
79 | MP0003191_abnormal_cellular_cholesterol | 1.08499578 |
80 | MP0003724_increased_susceptibility_to | 1.07248031 |
81 | MP0008438_abnormal_cutaneous_collagen | 1.02345398 |
82 | MP0001216_abnormal_epidermal_layer | 1.02324720 |
83 | MP0003806_abnormal_nucleotide_metabolis | 1.01009330 |
84 | MP0009278_abnormal_bone_marrow | 0.98969039 |
85 | MP0005257_abnormal_intraocular_pressure | 0.98775151 |
86 | MP0005076_abnormal_cell_differentiation | 0.97999843 |
87 | MP0006054_spinal_hemorrhage | 0.97309048 |
88 | MP0003329_amyloid_beta_deposits | 0.95496305 |
89 | MP0001730_embryonic_growth_arrest | 0.94170416 |
90 | MP0005623_abnormal_meninges_morphology | 0.92649813 |
91 | MP0002060_abnormal_skin_morphology | 0.91570453 |
92 | MP0008007_abnormal_cellular_replicative | 0.90173480 |
93 | MP0005083_abnormal_biliary_tract | 0.89310901 |
94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88527083 |
95 | MP0005666_abnormal_adipose_tissue | 0.88014804 |
96 | MP0000609_abnormal_liver_physiology | 0.87593404 |
97 | MP0005166_decreased_susceptibility_to | 0.87338786 |
98 | MP0001348_abnormal_lacrimal_gland | 0.87237672 |
99 | MP0003279_aneurysm | 0.87091569 |
100 | MP0000767_abnormal_smooth_muscle | 0.85523576 |
101 | MP0009931_abnormal_skin_appearance | 0.83387410 |
102 | MP0001661_extended_life_span | 0.82250232 |
103 | MP0000604_amyloidosis | 0.82048186 |
104 | MP0000358_abnormal_cell_content/ | 0.81981465 |
105 | MP0005390_skeleton_phenotype | 0.81098993 |
106 | MP0003718_maternal_effect | 0.80278470 |
107 | MP0000598_abnormal_liver_morphology | 0.79957679 |
108 | MP0009764_decreased_sensitivity_to | 0.79502720 |
109 | MP0005375_adipose_tissue_phenotype | 0.78809918 |
110 | MP0000313_abnormal_cell_death | 0.78521377 |
111 | MP0009763_increased_sensitivity_to | 0.78326239 |
112 | MP0000733_abnormal_muscle_development | 0.76424768 |
113 | MP0002138_abnormal_hepatobiliary_system | 0.75655597 |
114 | MP0003795_abnormal_bone_structure | 0.74732823 |
115 | MP0002139_abnormal_hepatobiliary_system | 0.74503083 |
116 | MP0004264_abnormal_extraembryonic_tissu | 0.74038413 |
117 | MP0005165_increased_susceptibility_to | 0.73530160 |
118 | MP0005621_abnormal_cell_physiology | 0.73294196 |
119 | MP0000350_abnormal_cell_proliferation | 0.70603903 |
120 | MP0003091_abnormal_cell_migration | 0.69595475 |
121 | MP0009697_abnormal_copulation | 0.69271336 |
122 | MP0003453_abnormal_keratinocyte_physiol | 0.69087607 |
123 | MP0003186_abnormal_redox_activity | 0.67857111 |
124 | * MP0000249_abnormal_blood_vessel | 0.67732586 |
125 | MP0002132_abnormal_respiratory_system | 0.66289175 |
126 | MP0008260_abnormal_autophagy | 0.65981299 |
127 | MP0005451_abnormal_body_composition | 0.64250726 |
128 | MP0001851_eye_inflammation | 0.63540877 |
129 | MP0010094_abnormal_chromosome_stability | 0.61778518 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00369837 |
2 | Recurrent abscess formation (HP:0002722) | 3.64323501 |
3 | Eczematoid dermatitis (HP:0000976) | 3.54707245 |
4 | IgM deficiency (HP:0002850) | 3.44663735 |
5 | Nasal polyposis (HP:0100582) | 3.28622322 |
6 | Chronic otitis media (HP:0000389) | 3.28109447 |
7 | Pustule (HP:0200039) | 3.21103320 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.16086034 |
9 | Recurrent fungal infections (HP:0002841) | 3.15267223 |
10 | Dysostosis multiplex (HP:0000943) | 3.10954063 |
11 | Myositis (HP:0100614) | 3.09816783 |
12 | Thrombocytosis (HP:0001894) | 3.05596081 |
13 | Abnormality of the nasal mucosa (HP:0000433) | 3.02178289 |
14 | Petechiae (HP:0000967) | 2.92525124 |
15 | Abnormality of T cells (HP:0002843) | 2.85373439 |
16 | Abnormality of macrophages (HP:0004311) | 2.82568518 |
17 | Abnormality of T cell physiology (HP:0011840) | 2.77868038 |
18 | Recurrent bronchitis (HP:0002837) | 2.77555533 |
19 | Recurrent skin infections (HP:0001581) | 2.67838643 |
20 | Vertebral compression fractures (HP:0002953) | 2.66236543 |
21 | Vacuolated lymphocytes (HP:0001922) | 2.65031059 |
22 | T lymphocytopenia (HP:0005403) | 2.63020487 |
23 | Abnormality of T cell number (HP:0011839) | 2.62332505 |
24 | Recurrent viral infections (HP:0004429) | 2.61003443 |
25 | Increased cerebral lipofuscin (HP:0011813) | 2.59771609 |
26 | Entropion (HP:0000621) | 2.59386373 |
27 | Osteolytic defects of the hand bones (HP:0009699) | 2.55146197 |
28 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.55146197 |
29 | Interstitial pulmonary disease (HP:0006530) | 2.55054230 |
30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54844102 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54844102 |
32 | Gastrointestinal inflammation (HP:0004386) | 2.50618370 |
33 | Thin bony cortex (HP:0002753) | 2.48666857 |
34 | Fatigue (HP:0012378) | 2.48487740 |
35 | Mucopolysacchariduria (HP:0008155) | 2.45852681 |
36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45852681 |
37 | Hyperacusis (HP:0010780) | 2.45746976 |
38 | Premature rupture of membranes (HP:0001788) | 2.44481032 |
39 | Cellulitis (HP:0100658) | 2.38682778 |
40 | Protrusio acetabuli (HP:0003179) | 2.34642501 |
41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32872596 |
42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32290784 |
43 | Gastrointestinal infarctions (HP:0005244) | 2.32247852 |
44 | Leukocytosis (HP:0001974) | 2.30841387 |
45 | Autoimmune thrombocytopenia (HP:0001973) | 2.30077552 |
46 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.28463569 |
47 | Combined immunodeficiency (HP:0005387) | 2.27384871 |
48 | Orchitis (HP:0100796) | 2.27355598 |
49 | Achilles tendon contracture (HP:0001771) | 2.27031762 |
50 | Peritonitis (HP:0002586) | 2.25824782 |
51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25402577 |
52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25402577 |
53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25402577 |
54 | Upper motor neuron abnormality (HP:0002127) | 2.23999784 |
55 | Inflammation of the large intestine (HP:0002037) | 2.22724899 |
56 | Ragged-red muscle fibers (HP:0003200) | 2.20958176 |
57 | IgG deficiency (HP:0004315) | 2.19432039 |
58 | Vasculitis (HP:0002633) | 2.19246661 |
59 | Gingivitis (HP:0000230) | 2.17897811 |
60 | Mediastinal lymphadenopathy (HP:0100721) | 2.17627807 |
61 | Chronic diarrhea (HP:0002028) | 2.15937721 |
62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15359355 |
63 | Distal lower limb muscle weakness (HP:0009053) | 2.15355452 |
64 | Axonal loss (HP:0003447) | 2.12843647 |
65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12048183 |
66 | Increased connective tissue (HP:0009025) | 2.11351510 |
67 | Gastrointestinal stroma tumor (HP:0100723) | 2.10095494 |
68 | Cervical subluxation (HP:0003308) | 2.09751116 |
69 | Lymphopenia (HP:0001888) | 2.07179058 |
70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07047715 |
71 | Arterial thrombosis (HP:0004420) | 2.06749675 |
72 | Fragile skin (HP:0001030) | 2.05403290 |
73 | Polygenic inheritance (HP:0010982) | 2.04332635 |
74 | Asymmetric septal hypertrophy (HP:0001670) | 2.04221756 |
75 | Severe combined immunodeficiency (HP:0004430) | 2.03212126 |
76 | Progressive muscle weakness (HP:0003323) | 2.02691969 |
77 | Obstructive lung disease (HP:0006536) | 1.99463198 |
78 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99463198 |
79 | Increased density of long bones (HP:0006392) | 1.98405124 |
80 | Emphysema (HP:0002097) | 1.98177199 |
81 | Biconcave vertebral bodies (HP:0004586) | 1.97285462 |
82 | Myocardial infarction (HP:0001658) | 1.96946060 |
83 | Joint stiffness (HP:0001387) | 1.96932078 |
84 | Progressive neurologic deterioration (HP:0002344) | 1.96877259 |
85 | Increased IgE level (HP:0003212) | 1.96846098 |
86 | Distal lower limb amyotrophy (HP:0008944) | 1.96696649 |
87 | Nuclear cataract (HP:0100018) | 1.96513665 |
88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96470725 |
89 | Abnormality of the Achilles tendon (HP:0005109) | 1.96384924 |
90 | Bone pain (HP:0002653) | 1.94879844 |
91 | Pulmonary infiltrates (HP:0002113) | 1.93606235 |
92 | Hypergammaglobulinemia (HP:0010702) | 1.92504207 |
93 | Increased serum ferritin (HP:0003281) | 1.92239060 |
94 | Basal ganglia calcification (HP:0002135) | 1.92181548 |
95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.90341793 |
96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.90341793 |
97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.90341793 |
98 | Short nail (HP:0001799) | 1.88756458 |
99 | Dilatation of the ascending aorta (HP:0005111) | 1.88517827 |
100 | Hypertensive crisis (HP:0100735) | 1.88475054 |
101 | Colitis (HP:0002583) | 1.88414291 |
102 | Trismus (HP:0000211) | 1.87547773 |
103 | Increased IgM level (HP:0003496) | 1.86586652 |
104 | Pathologic fracture (HP:0002756) | 1.86309009 |
105 | Abnormality of eosinophils (HP:0001879) | 1.86023923 |
106 | Polycythemia (HP:0001901) | 1.85370745 |
107 | Amaurosis fugax (HP:0100576) | 1.84825054 |
108 | Cerebral aneurysm (HP:0004944) | 1.84818923 |
109 | Microretrognathia (HP:0000308) | 1.84038741 |
110 | Genu recurvatum (HP:0002816) | 1.83620536 |
111 | Anorexia (HP:0002039) | 1.83570280 |
112 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83405220 |
113 | * Epistaxis (HP:0000421) | 1.82889263 |
114 | Agnosia (HP:0010524) | 1.82434978 |
115 | Long palpebral fissure (HP:0000637) | 1.80843356 |
116 | Amyloidosis (HP:0011034) | 1.80244056 |
117 | Radial bowing (HP:0002986) | 1.80237907 |
118 | Abnormality of nail color (HP:0100643) | 1.80214960 |
119 | Loss of speech (HP:0002371) | 1.79573849 |
120 | Thyroiditis (HP:0100646) | 1.79227167 |
121 | Purpura (HP:0000979) | 1.77575532 |
122 | Abnormality of the thoracic spine (HP:0100711) | 1.76683180 |
123 | Personality changes (HP:0000751) | 1.75817723 |
124 | Cerebral inclusion bodies (HP:0100314) | 1.75814020 |
125 | Generalized amyotrophy (HP:0003700) | 1.75320443 |
126 | Skin ulcer (HP:0200042) | 1.75115672 |
127 | Aplastic anemia (HP:0001915) | 1.74083874 |
128 | Urticaria (HP:0001025) | 1.74019594 |
129 | Hepatosplenomegaly (HP:0001433) | 1.73655113 |
130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73552299 |
131 | Thoracic kyphosis (HP:0002942) | 1.73101850 |
132 | Atrophic scars (HP:0001075) | 1.72776447 |
133 | Broad face (HP:0000283) | 1.72634948 |
134 | Blue sclerae (HP:0000592) | 1.72306343 |
135 | Hemoptysis (HP:0002105) | 1.71228640 |
136 | Systemic lupus erythematosus (HP:0002725) | 1.70854699 |
137 | Micronodular cirrhosis (HP:0001413) | 1.70711544 |
138 | IgA deficiency (HP:0002720) | 1.70406519 |
139 | Poor head control (HP:0002421) | 1.70401011 |
140 | Rough bone trabeculation (HP:0100670) | 1.70010143 |
141 | Ulnar bowing (HP:0003031) | 1.70007960 |
142 | Retrobulbar optic neuritis (HP:0100654) | 1.69739332 |
143 | Neuronal loss in central nervous system (HP:0002529) | 1.68553298 |
144 | Hyperparathyroidism (HP:0000843) | 1.66098440 |
145 | Flat acetabular roof (HP:0003180) | 1.65390853 |
146 | Abnormal ossification of hand bones (HP:0005921) | 1.64875396 |
147 | Increased variability in muscle fiber diameter (HP:0003557) | 1.63649451 |
148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.62464737 |
149 | Meningitis (HP:0001287) | 1.62430548 |
150 | Abnormal trabecular bone morphology (HP:0100671) | 1.61743139 |
151 | Spondylolisthesis (HP:0003302) | 1.61459524 |
152 | Bulbar palsy (HP:0001283) | 1.59994661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.74499940 |
2 | IRAK3 | 3.68851669 |
3 | SMG1 | 3.54036148 |
4 | NME2 | 3.42798318 |
5 | PRPF4B | 3.05849708 |
6 | TRIB3 | 2.93418894 |
7 | ERN1 | 2.63972432 |
8 | EEF2K | 2.41952628 |
9 | SCYL2 | 2.40346311 |
10 | JAK3 | 2.39612432 |
11 | TESK2 | 2.33514296 |
12 | ZAP70 | 2.30171809 |
13 | TYK2 | 2.29229599 |
14 | TBK1 | 2.26471852 |
15 | STK10 | 2.24429883 |
16 | PIM2 | 2.03949943 |
17 | BLK | 1.98340113 |
18 | BUB1 | 1.93112492 |
19 | TAOK2 | 1.89856050 |
20 | KIT | 1.87587292 |
21 | LRRK2 | 1.78736634 |
22 | ICK | 1.76109430 |
23 | RIPK1 | 1.75414525 |
24 | PKN2 | 1.73252063 |
25 | NEK2 | 1.71689703 |
26 | BTK | 1.66726810 |
27 | MAP3K8 | 1.61524692 |
28 | RPS6KA4 | 1.61280883 |
29 | KDR | 1.59156519 |
30 | JAK1 | 1.58333381 |
31 | FLT3 | 1.56184647 |
32 | EPHA2 | 1.44115843 |
33 | TTN | 1.34545565 |
34 | FGFR4 | 1.33146251 |
35 | WEE1 | 1.26564512 |
36 | CSF1R | 1.23523024 |
37 | MAP3K1 | 1.22786154 |
38 | SYK | 1.14506954 |
39 | MAP3K10 | 1.14362011 |
40 | EIF2AK1 | 1.13835529 |
41 | TXK | 1.12503775 |
42 | PIM1 | 1.12491446 |
43 | MAP2K3 | 1.12184013 |
44 | IKBKB | 1.10945475 |
45 | TSSK6 | 1.06325759 |
46 | BCKDK | 1.05846724 |
47 | IKBKE | 1.02846807 |
48 | LCK | 1.02769227 |
49 | GRK6 | 1.01521579 |
50 | HCK | 1.01048867 |
51 | ITK | 1.00211153 |
52 | MAP3K14 | 0.99946151 |
53 | IRAK2 | 0.98581845 |
54 | TESK1 | 0.98045673 |
55 | MST1R | 0.97963987 |
56 | EPHB1 | 0.96833298 |
57 | CSK | 0.94764176 |
58 | MAP3K11 | 0.92892807 |
59 | CDC42BPA | 0.88214411 |
60 | PAK4 | 0.87929756 |
61 | RPS6KA2 | 0.87200198 |
62 | IRAK4 | 0.86275304 |
63 | PDPK1 | 0.85122164 |
64 | JAK2 | 0.83068259 |
65 | MAP3K13 | 0.82541483 |
66 | MAP3K5 | 0.81875722 |
67 | STK3 | 0.80581226 |
68 | RPS6KL1 | 0.80480660 |
69 | RPS6KC1 | 0.80480660 |
70 | TEC | 0.80452244 |
71 | FGR | 0.79851764 |
72 | PDGFRA | 0.79833845 |
73 | MAPKAPK3 | 0.77794136 |
74 | PRKD2 | 0.76643277 |
75 | RAF1 | 0.76244689 |
76 | DDR2 | 0.76034883 |
77 | CLK1 | 0.75769526 |
78 | ARAF | 0.71937204 |
79 | LYN | 0.70143594 |
80 | DYRK3 | 0.69124474 |
81 | PTK6 | 0.68613947 |
82 | ALK | 0.67178290 |
83 | PASK | 0.66969279 |
84 | TAOK1 | 0.66794109 |
85 | BRAF | 0.66403008 |
86 | MOS | 0.66370061 |
87 | RPS6KB2 | 0.63192717 |
88 | RIPK4 | 0.63182987 |
89 | CDK12 | 0.62561516 |
90 | NEK1 | 0.61254893 |
91 | MAP2K2 | 0.60575755 |
92 | KSR2 | 0.60531841 |
93 | TAOK3 | 0.59975211 |
94 | BMX | 0.59640494 |
95 | CDK4 | 0.59334726 |
96 | PAK1 | 0.59199046 |
97 | MELK | 0.58876898 |
98 | TGFBR2 | 0.58871857 |
99 | BRSK2 | 0.58306312 |
100 | NEK9 | 0.58222384 |
101 | MTOR | 0.58167723 |
102 | CHUK | 0.56053132 |
103 | RPS6KA6 | 0.55533371 |
104 | ILK | 0.53916470 |
105 | TRPM7 | 0.53903566 |
106 | STK4 | 0.52328343 |
107 | CAMK1D | 0.49720823 |
108 | MAPK11 | 0.48725293 |
109 | CDK6 | 0.48551740 |
110 | PDK1 | 0.48436469 |
111 | MATK | 0.47383233 |
112 | PLK1 | 0.46244814 |
113 | AURKB | 0.45786132 |
114 | MAP3K3 | 0.45552076 |
115 | MAPK12 | 0.44099808 |
116 | EPHA3 | 0.42676869 |
117 | PRKG2 | 0.40960556 |
118 | MARK2 | 0.40821821 |
119 | AURKA | 0.40821716 |
120 | PAK2 | 0.40518734 |
121 | TLK1 | 0.40061947 |
122 | MAP2K6 | 0.39249136 |
123 | MAPKAPK2 | 0.39130840 |
124 | DAPK3 | 0.38359247 |
125 | SIK1 | 0.37234231 |
126 | SIK3 | 0.37159020 |
127 | HIPK2 | 0.37156431 |
128 | LMTK2 | 0.36921160 |
129 | PTK2 | 0.36820336 |
130 | LIMK1 | 0.36211623 |
131 | ABL2 | 0.35895817 |
132 | NLK | 0.35172824 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55499328 |
2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.50379870 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14819716 |
4 | RNA polymerase_Homo sapiens_hsa03020 | 2.08459539 |
5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98968984 |
6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.97866963 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88801709 |
8 | Measles_Homo sapiens_hsa05162 | 1.88033792 |
9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86698535 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86650505 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86319666 |
12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.72340148 |
13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.67594456 |
14 | Lysosome_Homo sapiens_hsa04142 | 1.66326367 |
15 | DNA replication_Homo sapiens_hsa03030 | 1.65506387 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65429729 |
17 | Shigellosis_Homo sapiens_hsa05131 | 1.62901975 |
18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.61088712 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.60398737 |
20 | Proteasome_Homo sapiens_hsa03050 | 1.59501928 |
21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56527880 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 1.54670647 |
23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.54591910 |
24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53377715 |
25 | Apoptosis_Homo sapiens_hsa04210 | 1.53282290 |
26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47582497 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.45895367 |
28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.44820503 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42803428 |
30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40729511 |
31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37197852 |
32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36792361 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35909424 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33217344 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32577235 |
36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31553863 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31045339 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30817736 |
39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29850316 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26668306 |
41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24148539 |
42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22349650 |
43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21644545 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21241128 |
45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20510531 |
46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19671806 |
47 | Malaria_Homo sapiens_hsa05144 | 1.16209990 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14568360 |
49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14501504 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.13830466 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12650795 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08821780 |
53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07718678 |
54 | Prion diseases_Homo sapiens_hsa05020 | 1.07413526 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.05200057 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 1.02514401 |
57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02402760 |
58 | Mismatch repair_Homo sapiens_hsa03430 | 1.01642866 |
59 | RNA transport_Homo sapiens_hsa03013 | 1.01195687 |
60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99191420 |
61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98778365 |
62 | Influenza A_Homo sapiens_hsa05164 | 0.96863729 |
63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96787631 |
64 | Ribosome_Homo sapiens_hsa03010 | 0.95457367 |
65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95009985 |
66 | Cell cycle_Homo sapiens_hsa04110 | 0.91250544 |
67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91197829 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.88831704 |
69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88543586 |
70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87680450 |
71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87618397 |
72 | Pertussis_Homo sapiens_hsa05133 | 0.86818633 |
73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86714186 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86585930 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86578354 |
76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84845586 |
77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84322644 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83151970 |
79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82494908 |
80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82328262 |
81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78096737 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76546647 |
83 | Spliceosome_Homo sapiens_hsa03040 | 0.75495146 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74537311 |
85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74088472 |
86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72620908 |
87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71953034 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71661897 |
89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71106210 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69929997 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69562990 |
92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69470472 |
93 | Salmonella infection_Homo sapiens_hsa05132 | 0.67742765 |
94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66316240 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.65993961 |
96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65942129 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.65328633 |
98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64259682 |
99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63484583 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63077220 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62683266 |
102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59999351 |
103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59625731 |
104 | Glioma_Homo sapiens_hsa05214 | 0.59411708 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57041107 |
106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56961717 |
107 | Alcoholism_Homo sapiens_hsa05034 | 0.56903635 |
108 | Asthma_Homo sapiens_hsa05310 | 0.55496691 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55249634 |
110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54250916 |
111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54165577 |
112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53537779 |
113 | Focal adhesion_Homo sapiens_hsa04510 | 0.53395572 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.52848196 |
115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52596729 |
116 | Platelet activation_Homo sapiens_hsa04611 | 0.52164110 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51429367 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50347388 |
119 | Hepatitis C_Homo sapiens_hsa05160 | 0.50086124 |
120 | Phagosome_Homo sapiens_hsa04145 | 0.47846404 |
121 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47589922 |
122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46527552 |
123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44493843 |
124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42565063 |
125 | Bladder cancer_Homo sapiens_hsa05219 | 0.41430938 |
126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40077397 |
127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39718417 |
128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39296090 |
129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39141329 |